Novartis’s Kisqali Strikes Gold In Adjuvant Early Breast Cancer Setting

$3bn More In Sales Projected

 
• By Ayisha Sharma
  
Two teapots, one with pink lid, one with no lid and dark hole, representing breasts and breast cancer
The Risk Of Breast Cancer Returning Peaks Three Years After Diagnosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category